Gene therapy competitive dynamics: Winner takes all
With many gene therapies in development for an increasing number of indications, their curative promise presents a unique competitive dynamic as they enter the...
Industries
Life Sciences Antitrust & Competition
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
Engagements
- 01At risk generic entry and impact of formulary statusIn a Hatch-Waxman litigation, a first-to-file generic manufacturer asked CRA to assess changes in formulary status that would result from the at-risk entry and...View engagement
- 02Evaluation of alleged manipulation of industry drug standard settingIn a matter involving alleged abuse of the U.S. Pharmacopeia standard setting process, CRA examined market power for product dispensed through hospital and...View engagement
- 03Alleged foreclosure from API supply agreementsCRA was retained by a plaintiff generic manufacturer in antitrust litigation involving an infused hospital pharmaceutical product. At issue were claims...View engagement